ARTICLE | Clinical News
Dopascan: Phase III testing update
April 5, 1999 7:00 AM UTC
Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. Product: Dopascan Business: Neurological Therapeutic category: Test Target: Dopamine transporter Description: Iodinated tropane derivative dopamine...